Publication | Closed Access

Anti-HER2/neu IgG3–(IL-2) and anti-HER2/neu IgG3–(GM-CSF) promote HER2/neu processing and presentation by dendritic cells: Implications in immunotherapy and vaccination strategies

VaccinationAnti-her2/neu Igg3–Her2/neu ProcessingImmunologyTumor ImmunityImmunologic MechanismT Cell ImmunityImmunomodulationImmunotherapeuticsDendritic Cell BiologyImmunotherapyMedicineCell BiologyImmune DysregulationDendritic Cells